Abstract
The Supreme Court's recent decision in Association for Molecular Pathology v. Myriad Genetics ([ 1 ][1]) was widely regarded for its conclusion that patents could not be held over isolated DNA. However, Myriad maintains a confidential library of BRCA variants of undetermined significance (VUSs) ([ 2
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
